This volume investigates the role and therapeutic potential of Cyclin-Dependent Kinase (CDK) inhibitors in cellular regulation and disease. It synthesizes current research on the molecular mechanisms of CDKs and their dysregulation in various pathologies, particularly cancer. The book aims to provide a comprehensive overview of the development and application of CDK inhibitors as targeted therapies.

This volume is recognized as a significant contribution to the field of molecular biology and cancer research, offering a detailed look at CDK inhibitors. The collection of works within this book provides a solid foundation for researchers and clinicians interested in targeted cancer therapies. Its focus on both fundamental mechanisms and clinical applications makes it a valuable resource for understanding the current state and future directions of CDK inhibitor development.